Oscar Raises 2026 Earnings Outlook, Sets 2029 Targets
Oscar Raises 2026 Earnings Outlook, Sets 2029 Targets
Anonymous
Key Points
1
Oscar’s earnings-from-operations guidance increased by $100 million at both ends of the range, from $500 million-$700 million to $600 million-$800 million.
2
Oscar described the medical loss ratio as the share of premium revenue paid out for medical claims, providing context for why the lower 81%-82% forecast represents improved cost performance.
3
The investor event was scheduled to begin at 9 a.m. Eastern time on Wednesday, with Oscar planning to present its strategy, long-term financial targets and updated outlook.
Oscar Health raised its 2026 earnings outlook to $600 million-$800 million, up $100 million at both ends, signaling confidence in its cost-control strategy Benzinga. The health insurer also narrowed its medical loss ratio — the share of premiums paid for medical claims — to 81%-82%, down from 81.5%-82.5%, reflecting improved operational discipline as it expands individual and small-business coverage.
At its September 16 investor event, Oscar laid out an ambitious long-term vision: at least $4 in earnings per share, 5%-7% profit margins, and roughly 20% annual revenue growth by 2029 TradingView. The company plans to reach these targets through AI-driven efficiency gains, product innovation, and expansion of its ACA marketplace presence.
Better Profits Through Higher Prices and Discipline
Oscar's upgraded 2026 outlook reflects its ability to raise prices and control medical costs. The insurer reaffirmed revenue guidance of $18.7 billion-$19 billion while expecting its SG&A expense ratio — spending on sales, general and administrative costs — to stay between 15.6% and 16.1% Benzinga. This combination shows Oscar can grow without letting costs spiral.
Ambitious 2029 Targets Don't Depend on Marketplace Success
Oscar's long-term goals are bold but grounded in core business growth. The company targets at least $4 earnings per share by 2029, along with 5%-7% profit margins and 20% annual revenue growth TradingView. Notably, Oscar said these targets do not depend on Lucie Health Marketplace succeeding, meaning the company sees a path to hit them through its traditional insurance operations.
Analyst Views Split on Oscar's Health and Valuation
Wall Street gave mixed reactions to the guidance boost. Benzinga reports that Stephens reiterated an Equal Weight rating with a $34 price target, signaling skepticism about near-term upside. But Benzinga also notes Barclays maintained Overweight and raised its target to $49, betting Oscar will deliver on its efficiency promises and expansion plans.
AI and ACA Expansion Drive Oscar's Growth Engine
Oscar's strategy centers on three pillars: AI-powered cost management, product innovation, and capturing more ACA individual market share through its Choice product TradingView. The company sees artificial intelligence as a way to improve claims processing and reduce unnecessary medical spending. Expanding ACA coverage — which serves people who don't get insurance through employers — is also key to hitting 20% annual revenue growth by 2029.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
14
Articles
12
Reach
26
A
AnonymousAuthor
